世界のスイッチOTC医薬品市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Rx to OTC Switches Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4840 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、スイッチOTC医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（鎮痛剤、抗感染薬、胃腸薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・スイッチOTC医薬品の市場動向 ・企業の競争状況、市場シェア ・スイッチOTC医薬品の種類別市場規模と予測2016-2027（鎮痛剤、抗感染薬、胃腸薬、その他） ・スイッチOTC医薬品の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局） ・スイッチOTC医薬品の北米市場規模2016-2027（アメリカ、カナダ） ・スイッチOTC医薬品の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・スイッチOTC医薬品のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・スイッチOTC医薬品の中南米市場規模2016-2027（メキシコ、ブラジル） ・スイッチOTC医薬品の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bayer、C. H. Boehringer Sohn、GlaxoSmithKline、Johnson & Johnson、Merck、Novartis、Pfizer、Sanofi） ・結論

While many areas of the pharmaceutical industry will suffer from current economic conditions worldwide, sales of over-the-counter drugs are widely anticipated to grow as consumers seek cheaper alternatives.

Market Analysis and Insights: Global Rx to OTC Switches Market
The global Rx to OTC Switches market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Rx to OTC Switches market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Rx to OTC Switches market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Rx to OTC Switches market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Rx to OTC Switches market.

Global Rx to OTC Switches Scope and Market Size
Rx to OTC Switches market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Rx to OTC Switches market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Analgesics
Anti-infectives
Gastrointestinal Drugs
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bayer
C. H. Boehringer Sohn
GlaxoSmithKline
Johnson & Johnson
Merck
Novartis
Pfizer
Sanofi

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rx to OTC Switches Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Analgesics
1.2.3 Anti-infectives
1.2.4 Gastrointestinal Drugs
1.2.5 Others
1.3 Market by Application
1.3.1 Global Rx to OTC Switches Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Rx to OTC Switches Market Perspective (2016-2027)
2.2 Rx to OTC Switches Growth Trends by Regions
2.2.1 Rx to OTC Switches Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Rx to OTC Switches Historic Market Share by Regions (2016-2021)
2.2.3 Rx to OTC Switches Forecasted Market Size by Regions (2022-2027)
2.3 Rx to OTC Switches Industry Dynamic
2.3.1 Rx to OTC Switches Market Trends
2.3.2 Rx to OTC Switches Market Drivers
2.3.3 Rx to OTC Switches Market Challenges
2.3.4 Rx to OTC Switches Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Rx to OTC Switches Players by Revenue
3.1.1 Global Top Rx to OTC Switches Players by Revenue (2016-2021)
3.1.2 Global Rx to OTC Switches Revenue Market Share by Players (2016-2021)
3.2 Global Rx to OTC Switches Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Rx to OTC Switches Revenue
3.4 Global Rx to OTC Switches Market Concentration Ratio
3.4.1 Global Rx to OTC Switches Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rx to OTC Switches Revenue in 2020
3.5 Rx to OTC Switches Key Players Head office and Area Served
3.6 Key Players Rx to OTC Switches Product Solution and Service
3.7 Date of Enter into Rx to OTC Switches Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Rx to OTC Switches Breakdown Data by Type
4.1 Global Rx to OTC Switches Historic Market Size by Type (2016-2021)
4.2 Global Rx to OTC Switches Forecasted Market Size by Type (2022-2027)

5 Rx to OTC Switches Breakdown Data by Application
5.1 Global Rx to OTC Switches Historic Market Size by Application (2016-2021)
5.2 Global Rx to OTC Switches Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Rx to OTC Switches Market Size (2016-2027)
6.2 North America Rx to OTC Switches Market Size by Type
6.2.1 North America Rx to OTC Switches Market Size by Type (2016-2021)
6.2.2 North America Rx to OTC Switches Market Size by Type (2022-2027)
6.2.3 North America Rx to OTC Switches Market Size by Type (2016-2027)
6.3 North America Rx to OTC Switches Market Size by Application
6.3.1 North America Rx to OTC Switches Market Size by Application (2016-2021)
6.3.2 North America Rx to OTC Switches Market Size by Application (2022-2027)
6.3.3 North America Rx to OTC Switches Market Size by Application (2016-2027)
6.4 North America Rx to OTC Switches Market Size by Country
6.4.1 North America Rx to OTC Switches Market Size by Country (2016-2021)
6.4.2 North America Rx to OTC Switches Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Rx to OTC Switches Market Size (2016-2027)
7.2 Europe Rx to OTC Switches Market Size by Type
7.2.1 Europe Rx to OTC Switches Market Size by Type (2016-2021)
7.2.2 Europe Rx to OTC Switches Market Size by Type (2022-2027)
7.2.3 Europe Rx to OTC Switches Market Size by Type (2016-2027)
7.3 Europe Rx to OTC Switches Market Size by Application
7.3.1 Europe Rx to OTC Switches Market Size by Application (2016-2021)
7.3.2 Europe Rx to OTC Switches Market Size by Application (2022-2027)
7.3.3 Europe Rx to OTC Switches Market Size by Application (2016-2027)
7.4 Europe Rx to OTC Switches Market Size by Country
7.4.1 Europe Rx to OTC Switches Market Size by Country (2016-2021)
7.4.2 Europe Rx to OTC Switches Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Rx to OTC Switches Market Size (2016-2027)
8.2 Asia-Pacific Rx to OTC Switches Market Size by Type
8.2.1 Asia-Pacific Rx to OTC Switches Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Rx to OTC Switches Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Rx to OTC Switches Market Size by Type (2016-2027)
8.3 Asia-Pacific Rx to OTC Switches Market Size by Application
8.3.1 Asia-Pacific Rx to OTC Switches Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Rx to OTC Switches Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Rx to OTC Switches Market Size by Application (2016-2027)
8.4 Asia-Pacific Rx to OTC Switches Market Size by Region
8.4.1 Asia-Pacific Rx to OTC Switches Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Rx to OTC Switches Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Rx to OTC Switches Market Size (2016-2027)
9.2 Latin America Rx to OTC Switches Market Size by Type
9.2.1 Latin America Rx to OTC Switches Market Size by Type (2016-2021)
9.2.2 Latin America Rx to OTC Switches Market Size by Type (2022-2027)
9.2.3 Latin America Rx to OTC Switches Market Size by Type (2016-2027)
9.3 Latin America Rx to OTC Switches Market Size by Application
9.3.1 Latin America Rx to OTC Switches Market Size by Application (2016-2021)
9.3.2 Latin America Rx to OTC Switches Market Size by Application (2022-2027)
9.3.3 Latin America Rx to OTC Switches Market Size by Application (2016-2027)
9.4 Latin America Rx to OTC Switches Market Size by Country
9.4.1 Latin America Rx to OTC Switches Market Size by Country (2016-2021)
9.4.2 Latin America Rx to OTC Switches Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Rx to OTC Switches Market Size (2016-2027)
10.2 Middle East & Africa Rx to OTC Switches Market Size by Type
10.2.1 Middle East & Africa Rx to OTC Switches Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Rx to OTC Switches Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Rx to OTC Switches Market Size by Type (2016-2027)
10.3 Middle East & Africa Rx to OTC Switches Market Size by Application
10.3.1 Middle East & Africa Rx to OTC Switches Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Rx to OTC Switches Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Rx to OTC Switches Market Size by Application (2016-2027)
10.4 Middle East & Africa Rx to OTC Switches Market Size by Country
10.4.1 Middle East & Africa Rx to OTC Switches Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Rx to OTC Switches Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Rx to OTC Switches Introduction
11.1.4 Bayer Revenue in Rx to OTC Switches Business (2016-2021)
11.1.5 Bayer Recent Development
11.2 C. H. Boehringer Sohn
11.2.1 C. H. Boehringer Sohn Company Details
11.2.2 C. H. Boehringer Sohn Business Overview
11.2.3 C. H. Boehringer Sohn Rx to OTC Switches Introduction
11.2.4 C. H. Boehringer Sohn Revenue in Rx to OTC Switches Business (2016-2021)
11.2.5 C. H. Boehringer Sohn Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Rx to OTC Switches Introduction
11.3.4 GlaxoSmithKline Revenue in Rx to OTC Switches Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Rx to OTC Switches Introduction
11.4.4 Johnson & Johnson Revenue in Rx to OTC Switches Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Rx to OTC Switches Introduction
11.5.4 Merck Revenue in Rx to OTC Switches Business (2016-2021)
11.5.5 Merck Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Rx to OTC Switches Introduction
11.6.4 Novartis Revenue in Rx to OTC Switches Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Rx to OTC Switches Introduction
11.7.4 Pfizer Revenue in Rx to OTC Switches Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Rx to OTC Switches Introduction
11.8.4 Sanofi Revenue in Rx to OTC Switches Business (2016-2021)
11.8.5 Sanofi Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Rx to OTC Switches Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Analgesics
Table 3. Key Players of Anti-infectives
Table 4. Key Players of Gastrointestinal Drugs
Table 5. Key Players of Others
Table 6. Global Rx to OTC Switches Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Rx to OTC Switches Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Rx to OTC Switches Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Rx to OTC Switches Market Share by Regions (2016-2021)
Table 10. Global Rx to OTC Switches Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Rx to OTC Switches Market Share by Regions (2022-2027)
Table 12. Rx to OTC Switches Market Trends
Table 13. Rx to OTC Switches Market Drivers
Table 14. Rx to OTC Switches Market Challenges
Table 15. Rx to OTC Switches Market Restraints
Table 16. Global Rx to OTC Switches Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Rx to OTC Switches Market Share by Players (2016-2021)
Table 18. Global Top Rx to OTC Switches Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rx to OTC Switches as of 2020)
Table 19. Ranking of Global Top Rx to OTC Switches Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Rx to OTC Switches Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Rx to OTC Switches Product Solution and Service
Table 23. Date of Enter into Rx to OTC Switches Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Rx to OTC Switches Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Rx to OTC Switches Revenue Market Share by Type (2016-2021)
Table 27. Global Rx to OTC Switches Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Rx to OTC Switches Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Rx to OTC Switches Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Rx to OTC Switches Revenue Market Share by Application (2016-2021)
Table 31. Global Rx to OTC Switches Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Rx to OTC Switches Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Rx to OTC Switches Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Rx to OTC Switches Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Rx to OTC Switches Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Rx to OTC Switches Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Rx to OTC Switches Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Rx to OTC Switches Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Rx to OTC Switches Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Rx to OTC Switches Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Rx to OTC Switches Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Rx to OTC Switches Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Rx to OTC Switches Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Rx to OTC Switches Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Rx to OTC Switches Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Rx to OTC Switches Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Rx to OTC Switches Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Rx to OTC Switches Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Rx to OTC Switches Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Rx to OTC Switches Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Rx to OTC Switches Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Rx to OTC Switches Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Rx to OTC Switches Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Rx to OTC Switches Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Rx to OTC Switches Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Rx to OTC Switches Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Rx to OTC Switches Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Rx to OTC Switches Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Rx to OTC Switches Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Rx to OTC Switches Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Rx to OTC Switches Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Rx to OTC Switches Market Size by Country (2022-2027) & (US$ Million)
Table 63. Bayer Company Details
Table 64. Bayer Business Overview
Table 65. Bayer Rx to OTC Switches Product
Table 66. Bayer Revenue in Rx to OTC Switches Business (2016-2021) & (US$ Million)
Table 67. Bayer Recent Development
Table 68. C. H. Boehringer Sohn Company Details
Table 69. C. H. Boehringer Sohn Business Overview
Table 70. C. H. Boehringer Sohn Rx to OTC Switches Product
Table 71. C. H. Boehringer Sohn Revenue in Rx to OTC Switches Business (2016-2021) & (US$ Million)
Table 72. C. H. Boehringer Sohn Recent Development
Table 73. GlaxoSmithKline Company Details
Table 74. GlaxoSmithKline Business Overview
Table 75. GlaxoSmithKline Rx to OTC Switches Product
Table 76. GlaxoSmithKline Revenue in Rx to OTC Switches Business (2016-2021) & (US$ Million)
Table 77. GlaxoSmithKline Recent Development
Table 78. Johnson & Johnson Company Details
Table 79. Johnson & Johnson Business Overview
Table 80. Johnson & Johnson Rx to OTC Switches Product
Table 81. Johnson & Johnson Revenue in Rx to OTC Switches Business (2016-2021) & (US$ Million)
Table 82. Johnson & Johnson Recent Development
Table 83. Merck Company Details
Table 84. Merck Business Overview
Table 85. Merck Rx to OTC Switches Product
Table 86. Merck Revenue in Rx to OTC Switches Business (2016-2021) & (US$ Million)
Table 87. Merck Recent Development
Table 88. Novartis Company Details
Table 89. Novartis Business Overview
Table 90. Novartis Rx to OTC Switches Product
Table 91. Novartis Revenue in Rx to OTC Switches Business (2016-2021) & (US$ Million)
Table 92. Novartis Recent Development
Table 93. Pfizer Company Details
Table 94. Pfizer Business Overview
Table 95. Pfizer Rx to OTC Switches Product
Table 96. Pfizer Revenue in Rx to OTC Switches Business (2016-2021) & (US$ Million)
Table 97. Pfizer Recent Development
Table 98. Sanofi Company Details
Table 99. Sanofi Business Overview
Table 100. Sanofi Revenue in Rx to OTC Switches Business (2016-2021) & (US$ Million)
Table 101. Sanofi Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rx to OTC Switches Market Share by Type: 2020 VS 2027
Figure 2. Analgesics Features
Figure 3. Anti-infectives Features
Figure 4. Gastrointestinal Drugs Features
Figure 5. Others Features
Figure 6. Global Rx to OTC Switches Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Rx to OTC Switches Report Years Considered
Figure 11. Global Rx to OTC Switches Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Rx to OTC Switches Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Rx to OTC Switches Market Share by Regions: 2020 VS 2027
Figure 14. Global Rx to OTC Switches Market Share by Regions (2022-2027)
Figure 15. Global Rx to OTC Switches Market Share by Players in 2020
Figure 16. Global Top Rx to OTC Switches Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rx to OTC Switches as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Rx to OTC Switches Revenue in 2020
Figure 18. Global Rx to OTC Switches Revenue Market Share by Type (2016-2021)
Figure 19. Global Rx to OTC Switches Revenue Market Share by Type (2022-2027)
Figure 20. North America Rx to OTC Switches Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Rx to OTC Switches Market Share by Type (2016-2027)
Figure 22. North America Rx to OTC Switches Market Share by Application (2016-2027)
Figure 23. North America Rx to OTC Switches Market Share by Country (2016-2027)
Figure 24. United States Rx to OTC Switches Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Rx to OTC Switches Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Rx to OTC Switches Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Rx to OTC Switches Market Share by Type (2016-2027)
Figure 28. Europe Rx to OTC Switches Market Share by Application (2016-2027)
Figure 29. Europe Rx to OTC Switches Market Share by Country (2016-2027)
Figure 30. Germany Rx to OTC Switches Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Rx to OTC Switches Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Rx to OTC Switches Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Rx to OTC Switches Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Rx to OTC Switches Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Rx to OTC Switches Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Rx to OTC Switches Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Rx to OTC Switches Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Rx to OTC Switches Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Rx to OTC Switches Market Share by Region (2016-2027)
Figure 40. China Rx to OTC Switches Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Rx to OTC Switches Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Rx to OTC Switches Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Rx to OTC Switches Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Rx to OTC Switches Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Rx to OTC Switches Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Rx to OTC Switches Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Rx to OTC Switches Market Share by Type (2016-2027)
Figure 48. Latin America Rx to OTC Switches Market Share by Application (2016-2027)
Figure 49. Latin America Rx to OTC Switches Market Share by Country (2016-2027)
Figure 50. Mexico Rx to OTC Switches Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Rx to OTC Switches Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Rx to OTC Switches Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Rx to OTC Switches Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Rx to OTC Switches Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Rx to OTC Switches Market Share by Country (2016-2027)
Figure 56. Turkey Rx to OTC Switches Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Rx to OTC Switches Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Rx to OTC Switches Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Bayer Revenue Growth Rate in Rx to OTC Switches Business (2016-2021)
Figure 60. C. H. Boehringer Sohn Revenue Growth Rate in Rx to OTC Switches Business (2016-2021)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Rx to OTC Switches Business (2016-2021)
Figure 62. Johnson & Johnson Revenue Growth Rate in Rx to OTC Switches Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in Rx to OTC Switches Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Rx to OTC Switches Business (2016-2021)
Figure 65. Pfizer Revenue Growth Rate in Rx to OTC Switches Business (2016-2021)
Figure 66. Sanofi Revenue Growth Rate in Rx to OTC Switches Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---